DUPUYTREN LITERATURE: CORTICOSTEROIDS

These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.

Medline Title Search (Dupuytren + Cortisone)

Selected Publications

• Baxter H, Schiller C, Johnson LH, et al. (1946) Cortisone therapy in Dupuytren’s contracture. Plastic and reconstructive surgery 1946,9(3): 261–73. (PDF)
• Ball C, Izadi D, Verjee LS, et al. (2016) Systematic review of non-surgical treatments for early dupuytren’s disease. BMC musculoskeletal disorders 17(1). BMC Musculoskeletal Disorders: 345. DOI: 10.1186/s12891-016-1200-y. (PDF)
• Debeyre N (1958) Traitement De La Maladie De Dupuytren Par Hydrocortisone Locale Associee Aux Manceuvres De Redressement (135 Cas Traites) [Treatment of Dupuytren’s disease by local hydrocortisone associated with straightening maneuvers; 135 treated cases]. Sem Therapeutique 34(7). 728–730. (PDF)
• Broekstra DC and Werker PM (2012) Steroid injections in combination with needle aponeurotomy as a treatment method for Dupuytren disease: suggestions for increasing the research evidence. J Hand Surg Am 37(11). 2012/10/30.: 2421–2429. DOI: 10.1016/j.jhsa.2012.08.037. (PDF)
• Freeman AG (1995) Topical treatment for Dupuytren’s contracture. Lancet 345(8946), 382. (PDF)
• Gosset J (1974) Dupuytren’s Disease And The Anatomy Of The Palmodigital Aponeuroses. In: Hueston J and Tubiana R (eds) Dupuytren’s Disease. London: Grune & Stratton, London, pp. 11–23. (PDF)
• Hueston JT (1992) Regression of Dupuytren’s contracture. J Hand Surg Br 17(4): 453–457. (PDF)
• Ketchum LD (2014) The Rationale for Treating the Nodule in Dupuytren’s Disease. Plastic and reconstructive surgery. Global open 2(12): e278. DOI: 10.1097/GOX.0000000000000249. (PDF)
• Ketchum LD and Donahue TK (2000) The injection of nodules of Dupuytren’s disease with triamcinolone acetonide . J Hand Surg Am 25(6): 162–1157. (PDF)
• McMillan C and Binhammer P (2012) Reply to comment on: Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized, controlled study. J Hand Surg Am 37A: 2430–2431. (PDF)
• McMillan C and Binhammer P (2012) Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized, controlled study . J Hand Surg Am 37(7): 112–1307. (PDF)
• McMillan C and Binhammer P (2014) Steroid injection and needle aponeurotomy for dupuytren disease: long-term follow-up of a randomized controlled trial. The Journal of hand surgery 39(10). 1942–7 (PDF)
• Meek RMD, McLellan S, Crossan JF, et al. (1999) Dupuytren’s disease. A model for the mechanism of fibrosis and its modulation by steroids. J Bone Joint Surg Br 81(4).732–738. (PDF)
• Meek RMD, McLellan S, Reilly J, et al. (2002) The effect of steroids on Dupuytren’s disease: role of programmed cell death. Journal of hand surgery (Edinburgh, Scotland) 27(3). 2002/06/21.: 270–273. (PDF)
• Naylor I, Coleman D, Coleman R, et al. (1994) Dupuytren’s Disease Pathobiochemistry and Clinical Management. In: Berger A, Delbruck A, Brenner P, et al. (eds) Dupuytren’s Disease Pathobiochemistry and Clinical Management, pp. 139–150. Available at: Springer-Verlag Berlin. (PDF)
• Ritchey SJ (1952) The use of cortisone in Dupuytren’s contracture. U S Armed Forces Med J 3(6). 1952/06/01.: 811–818. (PDF)
• Shelley WB and Shelley ED (1993) Response of Dupuytren’s contracture to high-potency topical steroid. Lancet (London, England) 342(8867): 366. (PDF)
• Sood A, Therattil PJ, Kim HJ, et al. (2015) Corticosteroid Injection in the Management of Dupuytren Nodules: A Review of the Literature. Eplasty 15: e42. Available at: http://www.ncbi.nlm.nih.gov/pubmed/26528378. (PDF)
• Wang, J. P., et al. (2018). “Corticosteroid inhibits differentiation of palmar fibromatosis-derived stem cells (FSCs) through downregulation of transforming growth factor-beta1 (TGF-beta1).” PLoS One 13(6): e0198326. (PDF)
• Yin C-Y, Yu H-HM, Wang J-P, et al. (2017) Long-term follow-up of Dupuytren disease after injection of triamcinolone acetonide in Chinese patients in Taiwan. The Journal of hand surgery, European volume 42(7): 678–682. (PDF)